International researchers summarize the current understanding of peptic disease and trace the development of a novel new drug for peptic disease therapy-sucralfate. Contributors present laboratory research along side data from clinical trials as well as from the practice of medicine. Articles discuss the history of sucralfate's development, mechanisms of action, clinical efficacy, and future directions for research. This volume will be of interest to scientists and clinicians working in gastroenterology and gastrointestinal physiology.

From the Back Cover

Current research on new therapeutic agents for the treatment of peptic disease have focused on a series of new compounds that may work by mechanisms other than neutralizing acid or suppressing acid secretion in the human stomach. Sucralfate is the first in this series of compounds to be available for use in clinical trials. Sucralfate explores the mechanisms of action of this novel compound that acts as a nonsystemic agent capable of successfully treating peptic disease. Highlighting the immense value of worldwide cooperation in sucralfate's development, international investigators provide an excellent summary of the latest progress in understanding peptic disease and sucralfate's role in its therapy. In addition to featuring experimental advances and results from clinical trials and actual medical practice, chapters provide a historical survey of the field; describe sucralfate's synthesis, various interactions, and clinical efficacy; and present future directions for research. Salient topics include: pathophysiology of peptic ulcer disease; chemistry of sucralfate; effect of sucralfate on gastric surfactant; effect of sucralfate on Helicobacter pylori; safety of sucralfate in clinical practice; and use sucralfate in nonulcer dyspepsia, gastritris, and duodenitis. A unique compilation of well-established findings and results from cutting-edge research, Sucralfate serves to bridge the gap between basic science and clinical applications in this fascinating area of gastroenterology and gastrointestinal physiology. The discussions also place sucralfate in the forefront of research and make it a springboard for future discoveries in gastrointestinal pathophysiology.

"About this title" may belong to another edition of this title.

Store Description

Visit Seller's Storefront

Seller's business information

Edward Bowditch Ltd
Exstowe, Exton, Exeter, EX3 0PP, United Kingdom

Sale & Shipping Terms

Terms of Sale

Legal entity name: Edward Bowditch Ltd
Legal entity form: Limited company
Business correspondence address: Exstowe, Exton, Exeter, EX3 0PP
Company registration number: 04916632
VAT registration: GB834241546
Authorised representative: Mr. E. Bowditch

Shipping Terms

Orders usually dispatched within two working days. Please note that at this time all domestic United Kingdom orders are sent by trackable UPS courier, we choose not to offer a lower cost alternative.

Shipping rates from United Kingdom to U.S.A.

Shipping rates from United Kingdom to U.S.A.
Order quantity	7 to 14 business days	2 to 3 business days
First item	US$ 16.68	US$ 33.35

Delivery times are set by sellers and vary by carrier and location. Orders passing through Customs may face delays and buyers are responsible for any associated duties or fees. Sellers may contact you regarding additional charges to cover any increased costs to ship your items.